3-(Methoxycarbonyl)-3-(2-phenoxyacetamido)-1,5-pentandioic acid

ID: ALA562155

Chembl Id: CHEMBL562155

PubChem CID: 45268734

Max Phase: Preclinical

Molecular Formula: C15H17NO8

Molecular Weight: 339.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)C(CC(=O)O)(CC(=O)O)NC(=O)COc1ccccc1

Standard InChI:  InChI=1S/C15H17NO8/c1-23-14(22)15(7-12(18)19,8-13(20)21)16-11(17)9-24-10-5-3-2-4-6-10/h2-6H,7-9H2,1H3,(H,16,17)(H,18,19)(H,20,21)

Standard InChI Key:  OAPKRAUFMYYLSD-UHFFFAOYSA-N

Associated Targets(non-human)

penP Beta-lactamase (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
nmcA Imipenem-hydrolyzing beta-lactamase (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase (730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla Beta-lactamase OXA-10 (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaVIM-4 Beta-lactamase VIM-4 (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 339.30Molecular Weight (Monoisotopic): 339.0954AlogP: 0.04#Rotatable Bonds: 9
Polar Surface Area: 139.23Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.40CX Basic pKa: CX LogP: 0.05CX LogD: -6.51
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.54Np Likeness Score: -0.48

References

1. Beck J, Vercheval L, Bebrone C, Herteg-Fernea A, Lassaux P, Marchand-Brynaert J..  (2009)  Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate.,  19  (13): [PMID:19467869] [10.1016/j.bmcl.2009.04.149]

Source